Bamburgh Capital, the independent corporate finance adviser, has advised on a strategic cross-border acquisition for one of the fastest-growing healthcare companies in the US.
Philadelphia-headquartered AscellaHealth LLC, a global partner that delivers end-to-end solutions to both life sciences and healthcare companies to enhance the quality of life for patients with complex, chronic conditions, has acquired UK-based CHAPPER healthcare, a family-owned leading global pharmaceutical distributor and wholesaler.
CHAPPER specialises in importing and exporting to more than 70 different countries with longstanding relationships with clients across Europe, Asia, Africa, Australia and the Americas. It is also a founding member of EUROPACCESS, a partnership of seven leading European companies providing streamlined and faster access to European healthcare systems by supporting its manufacturer partners in the distribution of their medicines.
This is a highly strategic acquisition for AscellaHealth, who have been working with Bamburgh Capital to support their international growth plan via commercial opportunities, partnerships and acquisitions for several months.
Bill Oldham, Chairman and President of AscellaHealth said: “The integration of CHAPPER healthcare into the AscellaHealth organisation consolidates overall global market leadership, unlocking new opportunities for market access and product commercialization throughout the global life sciences industry.”
“Our combined experience, expertise and capabilities strengthen the AscellaHealth customer value proposition for delivering innovative, end-to-end solutions and providing our market-leading patient support programs throughout the world.”
Mario Patone, CFO, AscellaHealth added: “A strategic transaction in the UK with access to global markets underscores our shared commitment to shaping the future of healthcare, driving business growth and expanding our international presence. This acquisition will significantly accelerate the global market reach and operational scale of both organizations”
Alex Clarkson, Co-founder and Director of Bamburgh Capital said: “AscellaHealth is one of the fastest growing US healthcare companies and we have enjoyed working with them to help further develop their international presence and capabilities. This was an off-market deal, that we originated and demonstrates our ability, drive and determination to identify strategic acquisitions for our international clients, build trust with vendors and then deliver an excellent outcome for all parties.”
